Business - CNBC
-
FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals
-
Seattle Seahawks begin sale process after Super Bowl win
-
As Walmart and Target head in different directions, all eyes are on their new CEOs
-
FDA chief Marty Makary says 'everything should be over the counter' unless drug is unsafe or addictive
-
Ford to follow Tesla Cybertruck with electrical tech in new EV pickup
-
CFTC defends its right to prediction market enforcement as states challenge platforms
-
Dave's Hot Chicken investors bet on birria with national franchise expansion plan
-
Netflix grants WBD waiver to reopen deal talks with Paramount, Sarandos says 'let them make a move'
-
Lakers governor Jeanie Buss talks year of transition, says father would have supported sale to Mark Walter
-
Lunar New Year gives luxury brands a chance to win back big spenders in China
-
AI disruption could spark a ‘shock to the system’ in credit markets, UBS analyst says
-
How packaging and logistics companies are automating their warehouses
-
Rivian tops fourth-quarter expectations, targets significant production increase
-
Spirit Airlines sells more planes, calls back 500 flight attendants from furlough ahead of spring break
-
Realtors report a 'new housing crisis' as January home sales tank more than 8%
-
American Airlines flight attendants picket as CEO tries to calm frustrated employees
-
Restaurant Brands shares fall despite earnings beat, strong international growth
-
McDonald’s earnings beat estimates as chain’s value push pays off
-
Why the largest U.S. auto dealer isn't interested in Chinese cars — for now
-
Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start